Zydus Wellness Ltd

Zydus Wellness Ltd

₹ 1,964 -0.28%
22 May - close price
About

Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)

Key Points

Business Segments:[1]
Zydus Wellness operates primarily in the consumer wellness sector. Its key segments include:
a)Food & Nutrition: Notable brands and products such as Glucon-D, Complan, and Sugar-Free.
b) Personal Care: This segment covers products like Everyuth, Scrubs Peel-off masks, and Nycil Prickly Heat Powder.

  • Market Cap 12,514 Cr.
  • Current Price 1,964
  • High / Low 2,484 / 1,493
  • Stock P/E 36.7
  • Book Value 891
  • Dividend Yield 0.25 %
  • ROCE 6.32 %
  • ROE 6.19 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 8.92% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.97% over last 3 years.
  • Dividend payout has been low at 11.0% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
640 696 429 416 713 702 440 403 783 841 493 462 913
498 548 413 388 568 586 423 390 620 686 473 447 723
Operating Profit 142 148 16 28 145 116 17 13 162 155 20 15 190
OPM % 22% 21% 4% 7% 20% 17% 4% 3% 21% 18% 4% 3% 21%
2 -1 1 1 -6 -12 4 3 4 5 10 4 1
Interest 6 4 3 4 5 5 6 6 6 4 1 3 4
Depreciation 6 6 6 6 7 6 6 6 6 5 5 5 13
Profit before tax 131 137 8 19 126 93 9 4 154 152 24 10 173
Tax % -1% -0% -4% -1% -15% -18% 31% 92% 3% 3% 12% 37% 1%
133 137 8 20 145 110 6 0 150 148 21 6 172
EPS in Rs 20.95 21.53 1.34 3.08 22.83 17.35 0.93 0.05 23.62 23.21 3.28 1.01 27.01
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
404 431 397 431 513 843 1,767 1,867 2,009 2,255 2,328 2,709
319 331 305 331 387 658 1,446 1,522 1,664 1,918 2,020 2,329
Operating Profit 85 100 91 99 125 185 321 344 345 337 308 380
OPM % 21% 23% 23% 23% 24% 22% 18% 18% 17% 15% 13% 14%
19 28 32 32 35 28 -33 -123 10 -5 -0 20
Interest 0 0 0 1 2 30 140 84 26 16 24 12
Depreciation -0 8 7 7 9 13 26 25 24 25 24 28
Profit before tax 104 120 117 124 150 171 121 112 306 291 260 359
Tax % 5% 7% 10% 10% 9% -0% -17% -6% -1% -7% -3% 3%
98 111 105 111 137 171 142 119 309 310 267 347
EPS in Rs 24.69 27.88 26.43 27.89 34.27 29.33 24.58 18.66 48.54 48.78 41.94 54.52
Dividend Payout % 24% 22% 25% 23% 23% 17% 20% 27% 10% 10% 12% 11%
Compounded Sales Growth
10 Years: 20%
5 Years: 9%
3 Years: 10%
TTM: 16%
Compounded Profit Growth
10 Years: 12%
5 Years: 14%
3 Years: 3%
TTM: 22%
Stock Price CAGR
10 Years: 7%
5 Years: 10%
3 Years: 8%
1 Year: 14%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 6%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 39 39 39 39 39 58 58 64 64 64 64 64
Reserves 286 367 439 518 652 3,329 3,403 4,504 4,780 5,059 5,294 5,608
-0 -0 -0 25 25 1,569 1,519 550 387 297 329 188
99 102 89 100 112 503 610 548 461 413 462 582
Total Liabilities 425 508 568 682 829 5,459 5,590 5,666 5,692 5,833 6,148 6,442
95 84 82 103 104 4,567 4,674 4,667 4,710 4,732 4,708 5,125
CWIP 0 0 0 0 0 10 4 4 12 13 10 15
Investments 5 -0 94 30 148 46 110 -0 27 70 78 36
324 423 391 550 577 835 802 995 943 1,018 1,354 1,266
Total Assets 425 508 568 682 829 5,459 5,590 5,666 5,692 5,833 6,148 6,442

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
91 69 90 77 69 149 259 287 237 92 246 380
13 29 -28 -72 -59 -4,092 -17 -10 -59 -85 -19 -224
-27 -27 -58 -6 -2 4,052 -260 -216 -234 -138 -26 -186
Net Cash Flow 77 71 4 -1 8 109 -18 60 -56 -132 201 -30

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 2 1 3 3 6 42 24 18 26 34 44 49
Inventory Days 108 76 73 127 113 393 168 158 135 146 150 148
Days Payable 191 146 191 264 254 662 289 189 136 100 116 122
Cash Conversion Cycle -82 -69 -116 -134 -135 -227 -97 -13 25 80 78 75
Working Capital Days -48 -37 -38 -36 -8 4 -3 12 31 65 71 64
ROCE % 35% 32% 26% 23% 22% 7% 6% 6% 6% 6% 5% 6%

Shareholding Pattern

Numbers in percentages

10 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
65.14% 65.36% 65.36% 66.45% 67.11% 68.54% 69.15% 69.62% 69.62% 69.62% 69.62% 69.64%
2.38% 3.24% 3.83% 3.87% 3.23% 3.42% 3.25% 3.26% 3.29% 3.36% 3.37% 3.29%
25.11% 23.78% 23.35% 22.18% 22.04% 20.22% 19.67% 19.41% 19.44% 20.37% 20.12% 19.76%
7.37% 7.62% 7.46% 7.51% 7.62% 7.81% 7.91% 7.71% 7.65% 6.67% 6.89% 7.30%
No. of Shareholders 66,84570,70968,96970,79073,02976,59075,36969,13863,97360,98164,03764,979

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls